ETHRIS

About:

ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.

Website: http://ethris.com/

Twitter/X: ethris_mrna

Top Investors: Bill & Melinda Gates Foundation, AstraZeneca, OrbiMed, Laureus Capital, HS LifeSciences

Description:

ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIM®RNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, lifestyle- or age-related, rare or frequent.